NU Clinical Site: A Pilot Phase II Double-Blind, Placebo-Controlled, Dosage Finding and Tolerability Study of Isradipine as a Disease Modifying Agent in Patients with Early Parkinson's Disease

  • Zadikoff, Cindy (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date11/30/08 → 11/29/11

Funding

  • Michael J. Fox Foundation for Parkinson's Research (Award Letter 11/18/08)